Meningitis scare shutters second pharmaceutical factory - Breaking News Allvoices

News Stories Related To: Meningitis scare shutters second pharmaceutical factory

Chicago : IL : USA | over 1 year ago  
A pharmaceutical company, Ameridose, founded by owners of the same pharmacy linked to a deadly meningitis outbreak, is recalling all of its products worldwide. Officials of the...
    • Clear
    • Share:
    • Share
    • Clear
    • Clear
    • Clear
    • Clear
     
  • Read full report
   Reach     Credibility Credibility of 5
Report Your News Got a similar story?
Add it to the network!

Or add related content to this report

Related news stories

  • Senate health chair wants new drug compound rules

      The Boston Globe | over 1 year ago
    The chairman of the Senate's health committee pledged Thursday to move ahead with legislation to tighten oversight of compounding pharmacies, amid a deadly outbreak caused by tainted specialty medications. But a top lobbyist for the compounding...
  • Meningitis outbreak: drug companies resist more FDA oversight

      The Guardian | over 1 year ago
    Reuters Lauren Smith, Beth Bell and Margaret Hamburg testify before a Senate committee on Capitol Hill. Photograph: Alex Wong/Getty Images US states should remain the primary regulators for compounding pharmacies, rather than the US Food and Drug...
  • Compounding industry opposes new laws

      Associated Press | over 1 year ago
    The top lobbyist representing compounding pharmacies will tell members of Congress that stricter federal oversight is unnecessary to oversee his industry, despite a deadly meningitis outbreak tied to contaminated medications. Testimony released ahead...
  • Feathers in Your Pills? New Jersey Personal Injury Lawyers at Console & ...

      PRWeb | over 1 year ago
    Federal investigators have uncovered a host of unsanitary conditions and safety violations at Ameridose, a drug compounding company that boasts some of the same owners currently tied to a national fungal meningitis outbreak responsible for deaths in...
  • Mass. official: Plenty of blame for pharmacy crisis

      Telegram & Gazette | over 1 year ago
    Massachusetts Health and Human Services Secretary JudyAnn Bigby said Wednesday that state overseers and the managers of a compounding pharmacy bear responsibility for a fatal, nationwide outbreak of fungal meningitis. Bigby told state lawmakers that...
  • Meningitis contd. - owner pleads the fifth

      PharmaGossip | over 1 year ago
    Barry Cadden, owner of the New England company whose contaminated drugs have sickened patients nationwide, repeatedly cited the Fifth Amendment on Wednesday, declining to answer lawmakers' questions about unsterile conditions at his plant and its...
  • House panel grills FDA about compounding pharmacies

      Washington Post | over 1 year ago
    She absolved the FDA of responsibility for the outbreak, which has killed 32 people and caused 461 infections in the past three months. Framingham, Mass., in 2002 and had been in periodic contact with the company since then. We have no reason to...
  • Lawmakers Clash With FDA Over Meningitis Outbreak

      National Public Radio | over 1 year ago
    Members of a House subcommittee clashed repeatedly Wednesday with U.S. Food and Drug Commissioner Margaret Hamburg over the outbreak of meningitis caused by contaminated steroid injections. During a tense hearing called to investigate the outbreak,...
  • Maryland Man Describes Ordeal after Steroid Shots; Calls for Stricter ...

      PRWeb | over 1 year ago
    A Maryland man still reeling from steroid injections from the New England Compounding Center added his voice to calls for tougher regulation of compounding pharmacies today, said his attorney, Robert K. November 14, 2012 A Maryland man still reeling...
  • FDA seeks more authority amid meningitis outbreak

      Turks and Caicos Free Press | over 1 year ago
    New England Compounding Center President, co-owner, and Director of Pharmacy Barry Cadden is sworn in on Capitol Hill in Washington, Wednesday, Nov. 14, 2012. AP) The head of the Food and Drug Administration asked Congress Wednesday for more...
  • Owner of firm linked to meningitis outbreak takes Fifth

      CNN | over 1 year ago
    The owner of a company linked to a deadly fungal meningitis outbreak cited his constitutional right to remain silent Wednesday before a congressional subcommittee investigating the firm and 32 deaths nationwide. Barry Cadden, owner and director of...
  • Meningitis outbreak: director at center of health scandal refuses to ...

      The Guardian | over 1 year ago
    New York New England Compounding Center president and co-owner Barry Cadden testifies on Capitol Hill. Photograph: Susan Walsh/AP The director of the pharmacy at the centre of a health scandal that has killed 32 people refused to answer questions...
  • System did not protect from meningitis

      United Press International | over 1 year ago
    The system failed to protect patients from preventable death from meningitis, a congresswoman from Colorado said at a hearing at the Capitol in Washington. Rep. Diana DeGette, D-Colo., a member of the House of Representative's Energy and Commerce...
  • Republicans grill FDA chief on meningitis outbreak

      Franklin Lakes Oakland Suburban News | over 1 year ago
    Republican lawmakers challenged the country's top medical regulator Wednesday to explain why her agency did not take action sooner against the specialty pharmacy at the center of a deadly meningitis outbreak. Food and Drug Administration Commissioner...
  • Key figure in meningitis outbreak expected to take Fifth Amendment in Hill ...

      Fox | over 1 year ago
    FoxNews.com The president of the company linked to the fatal meningitis outbreak declined Wednesday to testify on Capitol Hill following dramatic testimony from the wife of a victim who died in the outbreak. Barry Cadden, president of the now-...
  • FDA chief asks for greater control over compounded drugs

      Baltimore Sun | over 1 year ago
    Food and Drug Administration has asked Congress to strengthen federal authority over drug compounders that are not currently subject to the stringent FDA safety and efficacy standards imposed on drug manufacturers. FDA Commissioner Margaret Hamburg ,...
  • F.D.A. Asking for More Control Over Drug Compounding

      The New York Times | over 1 year ago
    The commissioner of the federal Food and Drug Administration will recommend changes in the regulatory landscape for compounding pharmacies, placing those that produce drugs on a large scale in a new category that would give the agency greater powers...
  • Key figure in meningitis outbreak expected to take Fifth Amendment in Hill ...

      Fox News | over 1 year ago
    FoxNews.com The president of the New England Compounding Center, which is linked to the fatal meningitis outbreak, is expected to invoke his Fifth Amendment rights Wednesday during a Capitol Hill hearing. The president, Barry Cadden, has been...
  • Owner of meningitis-linked pharmacy takes Fifth

      Seattle Post Intelligencer | over 1 year ago
    The owner and director of the specialty pharmacy tied to a deadly meningitis outbreak declined to testify Wednesday morning before a congressional committee investigating the matter. Barry Cadden , co-founder of the New England Compound Center , told...
  • Lawmakers in Washington and Boston holding hearings Wednesday on meningitis ...

      Boston Globe | over 1 year ago
    Cadden, who has not made any public comments since the outbreak began and the New England Compounding Center was shuttered last month, was subpoenaed to testify before the Oversight and Investigations Subcommittee of the US House Committee on Energy...
  • FDA chief seeks new powers to police pharmacies

      Denver Post | over 1 year ago
    Barry Cadden, co-founder of the New England Compound Center, told lawmakers he would use his Fifth Amendment right to not answer questions in order to avoid self-incrimination. After repeated questions by House lawmakers, Cadden told the House Energy...
  • FDA seeks new powers to police specialty pharmacies in wake of outbreak

      Star Tribune | over 1 year ago
    The country's top medical regulator is preparing to tell Congress that new laws are needed to police large specialty pharmacies like the one at the center of a deadly meningitis outbreak. Testimony released ahead of the first congressional hearing on...
  • 11/13 - Board members knew felon ran monitoring firm

      Boston Globe | over 1 year ago
    The Globe previously reported that Illinois-based Pharmacy Support Inc. was chosen by the Massachusetts Board of Registration in Pharmacy in January 2006 to review operations at New England Compounding Center -- the company now blamed for the...
  • Meds maker's owner sat on state task force

      Boston Herald | over 1 year ago
    Updated 4 hours ago Text size  S tate health officials already under fire for lax oversight of a Framingham compounding pharmacy at the center of a deadly nationwide meningitis outbreak now admit their agency appointed the firm's embattled owner to a...
  • 'Meningitis' pharmacy had many violations

      United Press International | over 1 year ago
    U.S. health officials say a six-week investigation found the pharmacy linked to the meningitis outbreak that killed 32 people has a long history of violations...Food and Drug Administration and the Massachusetts Department of Public Health said they...
  • State was lax on drug maker

      Boston.com | over 1 year ago
    State pharmacy regulators on at least two occasions in the past decade displayed indifference in their oversight of a troubled Framingham specialty pharmacy that has now been blamed for a national fungal meningitis outbreak, ­according to documents ­...
  • Meningitis outbreak: pharmacy flagged by FDA as early as 2003, records show

      The Guardian | over 1 year ago
    New York The New England Compounding Center in Framingham, Massachusetts. Photograph: Nicolaus Czarnecki/Zuma Press/Corbis The top public health official in Massachusetts has admitted that "troubling questions" remain over why regulators failed eight...
  • Mass DPH: Not clear why board backed off penalty

      Boston.com | over 1 year ago
    The head of the Massachusetts health department said investigators still don't know why state regulators backed off a severe penalty against a pharmacy now implicated in a deadly meningitis outbreak. Interim Commissioner Dr. Lauren Smith said...
  • Mass DPH: not clear why board backed off penalty

      Boston Herald | over 1 year ago
    T he head of the Massachusetts health department says investigators still don't know why regulators backed off a severe penalty against a pharmacy now implicated in a deadly meningitis outbreak. In 2004, after product safety and sterility problems at...
  • Contaminated pharmacy co-owner served on oversight board

      Boston Herald | over 1 year ago
    Updated 1 minute ago Text size  T he head of a Framingham compounding pharmacy tied to a deadly nationwide meningitis outbreak served on a state committee reviewing industry regulations even as his company was under federal investigation for...
  • Report: FDA wanted to close Framingham pharmacy in 2002

      Boston Herald | over 1 year ago
    More than a decade ago, federal health inspectors wanted to shut down the pharmacy linked to a recent deadly meningitis outbreak until it cleaned up its operations, according to congressional investigators. Nearly 440 people have been sickened by...
  • Report: Meningitis-linked firm not a drug maker in 2003

      Fox | over 1 year ago
    Reuters Government health regulators in 2003 told the pharmacy now at the center of a deadly meningitis outbreak that its drug compounding activities did not constitute a manufacturing operation that would merit strict federal safety standards, a...
  • Bugs, Birds & Ignored Complaints At A Compounder

      Pharmalot | over 1 year ago
    In the latest bit of evidence to raise disturbing questions about some compounding pharmacy operations and regulatory oversight, the FDA recently sent 14 investigators and three microbiologists to inspect Ameridose, which is owned by the same folks...
  • Gov't report: Meningitis-linked firm not a drug maker in 2003

      Fox News | over 1 year ago
    Reuters Government health regulators in 2003 told the pharmacy now at the center of a deadly meningitis outbreak that its drug compounding activities did not constitute a manufacturing operation that would merit strict federal safety standards, a...
  • Nadrich & Cohen Assesses the Growing Link Between Steroid Use and ...

      PRWeb | over 1 year ago
    Certain steroid injections have shown to greatly increase one's risk of developing meningitis. November 13, 2012 Nadrich & Cohen is issuing a consumer alert to back pain patients in California and all other states to alert their doctor if...
  • Wright & Schulte LLC Evaluating Fungal Meningitis Lawsuits as Case Count in ...

      PRWeb | over 1 year ago
    According to the latest update from the U.S. HAI/outbreaks/meningitis.html">http://www.cdc.gov/HAI/outbreaks/meningitis.html The CDC is also reporting that some patients being treated for fungal meningitis have developed spinal epidural abscess and...
  • FDA critical of Westboro plant

      Telegram & Gazette | over 1 year ago
    Federal health inspectors found numerous potential sources of contamination, including leaky ceilings and insects, at a drug-making facility that has the same founders as the specialty pharmacy linked to a deadly meningitis outbreak. The Food and...
  • Co-owner of pharmacy at center of meningitis outbreak was faulted

      Boston.com | over 1 year ago
    Pharmacist Barry Cadden, co-owner of the Framingham pharmacy blamed for the deadly national meningitis outbreak, has a long history of not cooperating with federal regulators, including one 2004 inspection when he initially denied having an eye...
  • House staff report recounts decade of problems with New England Compounding ...

      Washington Post | over 1 year ago
    The account describes the same problems at the heart of the ongoing scandal the contamination of medicines and the mass production of supposedly custom-made substances. It also sketches a portrait of one of the owners, businessman Barry J. Cadden,...
  • Report slams medication maker

      Boston Herald | over 1 year ago
    Updated 2 hours ago Text size  N auseating details from a month-long FDA inspection released yesterday allege that Westboro-based Ameridose failed to adequately investigate a variety of complaints of adverse reactions to their medications, just as...
  • FDA Finds Insects, Bird at Meningitis-Linked Pharmacy

      Epoch Times | over 1 year ago
    November 12, 2012 Investigators found insects, rodents, and a bird at a company linked to the Massachusetts pharmacy at the center of the multistate outbreak of fungal meningitis that killed 32 people and sickened hundreds, highlighting potential...
  • FDA: Problems found at another facility of parent company of pharmacy tied ...

      CNN Blog | over 1 year ago
    Federal inspectors found crawling insects, corroding walls and concerns about safety and quality safeguards at a  drug-making facility run by the company tied to a deadly meningitis outbreak, according to a report released today...Food and Drug...
  • Federal inspectors find a multitude of problems at Ameridose, a major ...

      Boston Globe | over 1 year ago
    Johnson, Globe Staff In a report released Monday afternoon, federal inspectors detailed 15 problems found at major hospital drug supplier Ameridose LLC, ranging from insufficient testing of the sterility and potency of the drugs it made to the...
  • FDA find bugs, flying bird, at affiliate of meningitis pharmacy

      Reuters | over 1 year ago
    Ameridose LLC, an affiliate of the New England Compounding Center at the heart of the deadly meningitis outbreak.
  • FDA finds contamination concerns at Ameridose

      The Boston Globe | over 1 year ago
    Federal health inspectors have found more than a dozen sterility problems, including insects, at a drugmaking facility with the same founders as the specialty pharmacy linked to a deadly meningitis outbreak. The Food and Drug Administration has...
  • CDC: Meningitis risk may be waning

      Boston Globe | over 1 year ago
    So, state and federal officials might have breathed a sigh of relief on Wednesday, which marked six weeks from the day drugs produced at the Framingham pharmacy were recalled and public health officials began collecting products leftover in physician'...


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.